D57.433, Sickle-cell thalassemia beta zero with cerebral vascular involvementICD-10-CM
No Prior Auth Required
Covered without prior authorization (high confidence)
CGS-J15-L38249, MolDX: Blood Product Molecular Antigen Typing
J15
CGS-J15-L34037, Flow Cytometry
J15
CGS-J15-L34045, Non-Invasive Vascular Studies
J15
CGS-J18-L34045, Non-Invasive Vascular Studies
J18
CGS-J18-L38249, MolDX: Blood Product Molecular Antigen Typing
J18
CGS-J18-L34037, Flow Cytometry
J18
A57110, Billing and Coding: MolDX: Blood Product Molecular Antigen Typing
J5
WPS-J5-L38441, MolDX: Blood Product Molecular Antigen Typing
J5
WPS-J5-L35753, Non-Invasive Cerebrovascular Studies
J5
A57592, Billing and Coding: Non-Invasive Cerebrovascular Studies
J5
A56758, Billing and Coding: Non-Invasive Vascular Studies
J6
NGS-J6-L33627, Non-Invasive Vascular Studies
J6
WPS-J8-L35753, Non-Invasive Cerebrovascular Studies
J8
WPS-J8-L38441, MolDX: Blood Product Molecular Antigen Typing
J8
NGS-JK-L33627, Non-Invasive Vascular Studies
JK
A58308, Billing and Coding: MolDX: Blood Product Molecular Antigen Typing
UHC-POL-adakveo-crizanlizumab-tmca, Adakveo (Crizanlizumab-Tmca)
A55717, Billing and Coding: Lab: Flow Cytometry
A56464, Billing and Coding: Flow Cytometry
A56697, Billing and Coding: Non-Invasive Vascular Studies
Ask Backwork about documentation requirements, denial risks, or coverage in your state.